Mass spectrometry technology contributed to a biomarker discovery for antibody therapeutics in cancer immunotherapyDiscovering a Biomarker for the Clinical Outcome of Cancer Patients treated with ipilimumab by Providence Cancer Institute, USA and Shimadzu Corporation